22
EN
!
Prevent safety cartridges coming into
contact with contaminated objects,
e.g. clothing. Dispose of contaminated
safety cartridges immediately.
!
Always use dermatologically safe inks
designed specifically for tattooing.
!
Avoid contact with freshly tattooed
skin. Protect freshly tattooed areas of
skin from dirt and from exposure to UV
light and sunlight.
!
Check on a regular basis if the SOL
Nova has become visibly contaminated
by the return flow of inks or bodily
fluids. If this has happened, in addition
to regular disinfection, you must
perform all the steps described in
chapter “Cleaning and maintaining the
SOL Nova” (see Page
29).
2.4
Contra-indications
Tattooing is
not
permitted in case of the
following:
•
Haemophilia or other blood-clotting
disorders
•
Currently taking blood thinning medi-
cation (e.g. Warfarin, Heparin, aspirin,
acetylsalicylic acid)
•
Uncontrolled diabetes mellitus
•
Any form of active acne in the area that
shall be tattooed
•
Dermatosis (e.g. skin tumours, keloids
or extreme tendency for keloid for-
mation, solar keratosis, warts and/or
moles) in the area that shall be tattooed
•
Open wounds and/or eczema and/or
rashes in the area that shall be tattooed
•
Scars in the area that shall be tattooed
•
Systemic infections and infectious dis-
eases (e.g. Hepatitis type A, B, C, D, E
or F; HIV infection) or acute local skin
infections (e.g. herpes, rosacea)
•
During chemotherapy, radiotherapy
or high-dosage corticosteroid therapy
(recommendation: from four weeks be-
fore the start until four weeks after the
end of the therapy)
•
Up to twelve months after a plastic sur-
gery operation in the area that shall be
tattooed
•
Up to six months after filler injections
in the area that shall be tattooed
•
Under the influence of alcohol and/or
drugs
•
Pregnancy and lactation
The treatment must be terminated
immediately in the event of:
•
Excessive perception of pain
•
Fainting/dizziness
2.5
Side-e
ff
ects
In some cases, minor side e
ff
ects can
arise during and after the tattooing
process. These side e
ff
ects are listed
below.
Frequent:
•
Localised bleeding in the area of the
tattooed skin
•
Pain and discomfort on the first day
after the tattooing process
•
Short-term inflammatory reactions,
erythema and/or oedema up to six
days after the tattooing process
•
Skin irritations (e.g. itching or
temperature increase), which normally
die out over the first 12 to 72 hours
after the tattooing process
•
Formation of scabs, which normally
recede in the first five days
•
Temporary peeling of the skin which
normally subsides within eight days
Cheyenne SOL Nova
